Hematology

Lung Cancer

Questions discussed in this category

How do you manage anticoagulation for patients with DVT/PE who have brain metastases?

Some medical oncologists tend to hold anticoagulation in patients who develop brain metastases for fear of causing intracranial hemorrhage. Is t...

3 Answers available

Is it reasonable to treat a solitary plasmacytoma of the lung parenchyma with SBRT?

What dose/fractionation?

1 Answer available

Do you use bevacizumab in patients with history of VTE (DVT/PE) who are stable on anticoagulation?

Would it make a difference if the VTE diagnosis occurs during bevacizumab therapy or whether it preceded the cancer diagnosis?

1 Answer available

Papers discussed in this category

Blood, 2015-07-23

Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023 Apr 19

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update.

Cancer, 2024 Jan 30

Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients.

Haematologica, 2025 Feb 06

Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulation.

Hematology. American Society of Hematology. Education Program, 2024 Dec 06

Management of anticoagulation in patients with brain metastasis.

J Craniofac Surg,

Place of Sterotactic Radiotherapy in Treatment of Extramedullary Plasmocytoma.

Related Topics in Hematology